Logo image of NCL

NORTHANN CORP (NCL) Stock Fundamental Analysis

NYSEARCA:NCL - American Stock Exchange - US66373M2008 - Common Stock

0.309  -0.01 (-3.44%)

After market: 0.3223 +0.01 (+4.3%)

Fundamental Rating

1

Taking everything into account, NCL scores 1 out of 10 in our fundamental rating. NCL was compared to 41 industry peers in the Building Products industry. NCL may be in some trouble as it scores bad on both profitability and health. NCL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

NCL had negative earnings in the past year.
In the past year NCL has reported a negative cash flow from operations.
NCL Yearly Net Income VS EBIT VS OCF VS FCFNCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M -2M 4M -4M -6M

1.2 Ratios

NCL has a Return On Assets of -28.44%. This is amonst the worse of the industry: NCL underperforms 95.00% of its industry peers.
With a Return On Equity value of -298.04%, NCL is not doing good in the industry: 92.50% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -28.44%
ROE -298.04%
ROIC N/A
ROA(3y)-14.56%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NCL Yearly ROA, ROE, ROICNCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

1.3 Margins

NCL has a Gross Margin of 28.23%. This is in the lower half of the industry: NCL underperforms 60.00% of its industry peers.
In the last couple of years the Gross Margin of NCL has declined.
NCL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.86%
GM growth 5YN/A
NCL Yearly Profit, Operating, Gross MarginsNCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 -20 -40

2

2. Health

2.1 Basic Checks

NCL does not have a ROIC to compare to the WACC, probably because it is not profitable.
NCL has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, NCL has an improved debt to assets ratio.
NCL Yearly Shares OutstandingNCL Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M 20M
NCL Yearly Total Debt VS Total AssetsNCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M

2.2 Solvency

NCL has an Altman-Z score of -0.27. This is a bad value and indicates that NCL is not financially healthy and even has some risk of bankruptcy.
NCL has a Altman-Z score of -0.27. This is amonst the worse of the industry: NCL underperforms 92.50% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that NCL is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.09, NCL is doing good in the industry, outperforming 72.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z -0.27
ROIC/WACCN/A
WACC9.95%
NCL Yearly LT Debt VS Equity VS FCFNCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M -2M -4M

2.3 Liquidity

A Current Ratio of 0.53 indicates that NCL may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.53, NCL is doing worse than 95.00% of the companies in the same industry.
A Quick Ratio of 0.19 indicates that NCL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.19, NCL is doing worse than 95.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.19
NCL Yearly Current Assets VS Current LiabilitesNCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M 10M

2

3. Growth

3.1 Past

The earnings per share for NCL have decreased strongly by -41.55% in the last year.
NCL shows a strong growth in Revenue. In the last year, the Revenue has grown by 47.13%.
Measured over the past years, NCL shows a small growth in Revenue. The Revenue has been growing by 2.19% on average per year.
EPS 1Y (TTM)-41.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%114%
Revenue 1Y (TTM)47.13%
Revenue growth 3Y2.19%
Revenue growth 5YN/A
Sales Q2Q%18.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NCL Yearly Revenue VS EstimatesNCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 10M 20M 30M
NCL Yearly EPS VS EstimatesNCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

NCL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NCL Price Earnings VS Forward Price EarningsNCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NCL Per share dataNCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NCL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NORTHANN CORP

NYSEARCA:NCL (1/22/2025, 4:10:02 PM)

After market: 0.3223 +0.01 (+4.3%)

0.309

-0.01 (-3.44%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.68%
Inst Owner Change0%
Ins Owners59.53%
Ins Owner Change0%
Market Cap10.62M
AnalystsN/A
Price TargetN/A
Short Float %0.42%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.68
P/FCF N/A
P/OCF N/A
P/B 7.64
P/tB 29.03
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.45
BVpS0.04
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.44%
ROE -298.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.23%
FCFM N/A
ROA(3y)-14.56%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.86%
GM growth 5YN/A
F-Score5
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.53
Quick Ratio 0.19
Altman-Z -0.27
F-Score5
WACC9.95%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%114%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)47.13%
Revenue growth 3Y2.19%
Revenue growth 5YN/A
Sales Q2Q%18.39%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-455.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-36.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.39%
OCF growth 3YN/A
OCF growth 5YN/A